Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • Resource and Technical Advances
    • Clinical Medicine
    • Reviews
    • Editorials
    • Perspectives
    • Top read articles
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Transfers
  • Advertising
  • Job board
  • Contact
Iron accelerates Fusobacterium nucleatum–induced CCL8 expression in macrophages and is associated with colorectal cancer progression
Taishi Yamane, … , Hideo Baba, Toshiro Moroishi
Taishi Yamane, … , Hideo Baba, Toshiro Moroishi
Published September 22, 2022
Citation Information: JCI Insight. 2022;7(21):e156802. https://doi.org/10.1172/jci.insight.156802.
View: Text | PDF
Research Article Oncology

Iron accelerates Fusobacterium nucleatum–induced CCL8 expression in macrophages and is associated with colorectal cancer progression

  • Text
  • PDF
Abstract

Accumulating evidence suggests that high levels of Fusobacterium nucleatum in colorectal tumor tissues can be associated with poor prognosis in patients with colorectal cancer (CRC); however, data regarding distinct prognostic subgroups in F. nucleatum–positive CRC remain limited. Herein, we demonstrate that high-iron status was associated with a worse prognosis in patients with CRC with F. nucleatum. Patients with CRC presenting elevated serum transferrin saturation exhibited preferential iron deposition in macrophages in the tumor microenvironment. In addition, F. nucleatum induced CCL8 expression in macrophages via the TLR4/NF-κB signaling pathway, which was inhibited by iron deficiency. Mechanistically, iron attenuated the inhibitory phosphorylation of NF-κB p65 by activating serine/threonine phosphatases, augmenting tumor-promoting chemokine production in macrophages. Our observations indicate a key role for iron in modulating the NF-κB signaling pathway and suggest its prognostic potential as a determining factor for interpatient heterogeneity in F. nucleatum–positive CRC.

Authors

Taishi Yamane, Yohei Kanamori, Hiroshi Sawayama, Hiromu Yano, Akihiro Nita, Yudai Ohta, Hironori Hinokuma, Ayato Maeda, Akiko Iwai, Takashi Matsumoto, Mayuko Shimoda, Mayumi Niimura, Shingo Usuki, Noriko Yasuda-Yoshihara, Masato Niwa, Yoshifumi Baba, Takatsugu Ishimoto, Yoshihiro Komohara, Tomohiro Sawa, Tasuku Hirayama, Hideo Baba, Toshiro Moroishi

×

Figure 6

High expression of CCL8 is associated with poor prognosis in patients with colorectal cancer.

Options: View larger image (or click on image) Download as PowerPoint
High expression of CCL8 is associated with poor prognosis in patients wi...
(A) CCL8 is highly expressed in colorectal cancer (CRC) tissues from patients with high TSAT levels. CCL8 staining was performed on paraffin-embedded CRC tissues from patients with normal (n = 50) or high (n = 8) TSAT levels. Scale bar: 50 μm. Data are presented as the mean ± SD. ***P < 0.001 (Mann-Whitney U test). (B) Macrophages produce CCL8 within CRC tissues. Costaining of CCL8 (shown in brown) and IBA1 (shown in green) was performed on paraffin-embedded CRC tissues from patients with high TSAT levels (n = 8). Scale bar: 20 μm. Data are presented as the mean ± SD. (C) Overall survival curves for patients with stage I–III CRC from The Cancer Genome Atlas data set with high expression of CCL8 (n = 82) or low expression of CCL8 (n = 410) are shown. The cutoff value of FPKM was 2.5. **P < 0.01 (log-rank test).

Copyright © 2023 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts